Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Background and study aims Depression and dementia are major public health problems in the UK. Depression is very common in people with early stage dementia and reduces quality of life and speeds up cognitive (mental) decline. Mindfulness-based cognitive therapy (MBCT) is an effective depression prevention programme. There have been promising results showing the benefits of mindfulness interventions for people with dementia, suggesting that it could reduce depressive symptoms and slow deterioration in cognitive functions. The aim of this study is to test the study design for a future full study to determine the effectiveness of MBCT at reducing depressive symptoms in people with early stage dementia. Who can participate? Patients with mild to moderate depression and early stages of dementia What does the study involve? Participants are randomly allocated to receive either immediate or delayed access to an eight-week MBCT programme. Participants are assessed for depression before and after the intervention. What are the possible benefits and risks of participating? Participants may benefit from the proposed treatment, which has very good evidence of its effectiveness for depression. There are no risks anticipated with participating in this study. Participants will be able to drop out at any stage if they wish to do so. If participants have any concerns following participation, they will be encouraged to use the contacts provided at information sheet. Where is the study run from? North East London NHS Foundation Trust (UK) When is the study starting and how long is it expected to run for? June 2016 to December 2017 Who is funding the study? University of Oxford (UK) Who is the main contact? Dr Elisa Aguirre
Inclusion criteria
- Comorbid depression and early stages of dementia